Translucence Biosystems recently took part in the Keystone meeting, "Drug Delivery to the Brain: Challenges and Progress," which was held in Breckinridge, CO from January 23-26, 2023. Our team collaborated with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. The CEO of Translucence Biosystems, Damian Wheeler, Ph.D., presented the findings in a poster titled "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."
The Keystone meeting provided a valuable opportunity for Translucence Biosystems to network with industry leaders and stay informed about the latest advancements in drug delivery research. We are grateful for the support of event organizers, Robert Thorne from Denali Therapeutics and Reina Bendayan from the University of Toronto.
Download a copy of our poster here.
Ask your question
Send us your questions and we will get back to you as soon as possible